awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q63229539-600DB3A5-CF7E-4B5E-90D8-4E1C8C73C6C4
Q63229539-600DB3A5-CF7E-4B5E-90D8-4E1C8C73C6C4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q63229539-600DB3A5-CF7E-4B5E-90D8-4E1C8C73C6C4
Study of the Pan-ERBB Inhibitor Neratinib Given in Combination With Everolimus, Palbociclib or Trametinib in Advanced Cancer Subjects With EGFR Mutation/Amplification, HER2 Mutation/Amplification, HER3/4 Mutation or KRAS Mutation
P859
Q63229539-600DB3A5-CF7E-4B5E-90D8-4E1C8C73C6C4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q63229539-600DB3A5-CF7E-4B5E-90D8-4E1C8C73C6C4
rank
NormalRank
type
BestRank
Statement
P859
University of Texas MD Anderson Cancer Center